Registres
Chaque registre avec son nombre de médicaments et quelques-uns d’entre eux.
États-Unis
FDA · 5 médicaments
- Dyanavel XR2MG/ML; 0.5MG BASE/ML · suspension, extended release · Tris Pharma INC
- Dyanavel XR 108MG; 2MG BASE · tablet, extended release · Tris Pharma INC
- Dyanavel XR 1512MG; 3MG BASE · tablet, extended release · Tris Pharma INC
- Dyanavel XR 2016MG; 4MG BASE · tablet, extended release · Tris Pharma INC
Tous les médicaments contenant Amphetamine aspartate/dextroamphetamine
Tous les registres, page par page. Dosages et conditionnements figurent sur la page de chaque médicament.
26 résultats
| Médicament | Registre | Dosage | Forme | Statut | Titulaire |
|---|---|---|---|---|---|
| Dyanavel XRAssociation | États-Unis | 2MG/ML; 0.5MG BASE/ML | suspension, extended release | Commercialisé | Tris Pharma INC |
| Dyanavel XR 5Association | États-Unis | 4MG; 1MG BASE | tablet, extended release | Commercialisé | Tris Pharma INC |
| Dyanavel XR 10Association | États-Unis | 8MG; 2MG BASE | tablet, extended release | Commercialisé | Tris Pharma INC |
| Dyanavel XR 15Association | États-Unis | 12MG; 3MG BASE | tablet, extended release | Commercialisé | Tris Pharma INC |
| Dyanavel XR 20Association | États-Unis | 16MG; 4MG BASE | tablet, extended release | Commercialisé | Tris Pharma INC |
| Dextroamphetamine Sulfate | États-Unis | 5MG/5ML | solution | Commercialisé | Tris Pharma INC |
| Dextroamphetamine Sulfate | États-Unis | 10MG, 15MG, 5MG | capsule, extended release | Commercialisé | Specgx LLC |
| Dextroamphetamine Sulfate | États-Unis | 10MG, 15MG, 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** … | tablet | Commercialisé | Aurolife Pharma LLC |
| Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate and Amp SulfateAssociation | États-Unis | 1.25MG; 1.25MG; 1.25MG; 1.25MG, 1.875MG; 1.875MG; 1.875MG; 1.875MG, 2.5MG; 2.5MG; 2.5MG; 2.5MG … | tablet | Commercialisé | Actavis Elizabeth |
| Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate and Amp SulfateAssociation | États-Unis | 1.25MG; 1.25MG; 1.25MG; 1.25MG, 12.5MG; 12.5MG; 12.5MG; 12.5MG, 2.5MG; 2.5MG; 2.5MG; 2.5MG … | capsule, extended release | Commercialisé | Ani Pharms |
| Dextroamphetamine Saccharate; Amphetamine Aspartate Monohydrate; Dextroamphetamine Sulfate; Amphetamine SulfateAssociation | États-Unis | 10MG, 15MG, 20MG … | capsule, extended release | Approbation provisoire | Corepharma |
| Dextroamp Saccharate,Amp Aspartate,Dextroamp Sulfate and Amp SulfateAssociation | États-Unis | 1.25MG; 1.25MG; 1.25MG; 1.25MG, 2.5MG; 2.5MG; 2.5MG; 2.5MG, 3.75MG; 3.75MG; 3.75MG; 3.75MG … | capsule, extended release | Non commercialisé | Barr Labs INC |
| Adderall XR 5Association | États-Unis | 1.25MG; 1.25MG; 1.25MG; 1.25MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adderall XR 10Association | États-Unis | 2.5MG; 2.5MG; 2.5MG; 2.5MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adderall XR 15Association | États-Unis | 3.75MG; 3.75MG; 3.75MG; 3.75MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adderall XR 20Association | États-Unis | 5MG; 5MG; 5MG; 5MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adderall XR 25Association | États-Unis | 6.25MG; 6.25MG; 6.25MG; 6.25MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adderall XR 30Association | États-Unis | 7.5MG; 7.5MG; 7.5MG; 7.5MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| MydayisAssociation | États-Unis | 12.5MG; 12.5MG; 12.5MG; 12.5MG, 3.125MG; 3.125MG; 3.125MG; 3.125MG, 6.25MG; 6.25MG; 6.25MG; 6.25MG … | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adderall 5Association | États-Unis | 1.25MG; 1.25MG; 1.25MG; 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Non commercialisé | Teva Womens |
| Adderall 10Association | États-Unis | 2.5MG; 2.5MG; 2.5MG; 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Non commercialisé | Teva Womens |
| Adderall 15Association | États-Unis | 3.75MG; 3.75MG; 3.75MG; 3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Non commercialisé | Teva Womens |
| Adderall 20Association | États-Unis | 5MG; 5MG; 5MG; 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Non commercialisé | Teva Womens |
| Adderall 30Association | États-Unis | 7.5MG; 7.5MG; 7.5MG; 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Non commercialisé | Teva Womens |
| Adderall 7.5Association | États-Unis | 1.875MG; 1.875MG; 1.875MG; 1.875MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Non commercialisé | Teva Womens |
En bref
- Registres
- 1
- Médicaments
- 5
- Laboratoires
- 1